Market Research Report
UAE In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)
|Published by||Mordor Intelligence LLP||Product code||391074|
|Published||Content info||70 Pages
Delivery time: 2-3 business days
|UAE In Vitro Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)|
|Published: June 1, 2020||Content info: 70 Pages||
The growth of the UAE in vitro diagnostics market can be attributed to factors, such as high prevalence of chronic and infectious diseases. Chronic diseases, such as cancer, diabetes, and various respiratory diseases, are posing as a global challenge.
According to the International Diabetes Federation, currently, 55 million people are suffering from diabetes in the MENA region. The current market is also growing due to the use of advanced technologies in the market studied.
There has been a paradigm shift from traditional diagnostics to a new generation diagnostics that work at the gene level. This was made possible by the inclusion of advanced technologies, such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS). Hence, these factors are expected to drive market growth.
Reagents Segment Holds the Largest Market Share
The major market players in the UAE in vitro diagnostics market are bioMerieux, QIAGEN, Abbott Laboratories, F Hoffmann-La Roche Ltd, and Siemens Healthineers AG, among others. The competition among manufacturers is increasing, with the increasing number of companies. Small manufacturers represent an unorganized market, due to the lower prices of their products.